In 2025, IPC advanced the priorities outlined in our strategic plan, strengthening research collaboration, expanding regional education, and progressing focused clinical initiatives that address real-world gaps in psoriasis care. This encompassed ongoing efforts in disease severity reclassification, defining topical failure, examining cardiometabolic impacts on psoriasis, addressing complex clinical scenarios, commencing development of a comprehensive textbook on psoriasis, and delivering continued regional education via our Masterclasses.
Throughout the year, our Board Members, Councilors, and Jr. Councilors led scientific discussions, educational programming, and collaborative initiatives that reflect IPC’s role as a global network of physician experts. From international symposia to clinical guidance efforts, these contributions continue to shape how psoriasis care evolves across regions.
We are grateful to the many individuals and partners who volunteer their time, expertise, and leadership to IPC’s work. Their contributions are reflected throughout the progress summarized in this report.
We invite you to view the Annual Report below to learn more about IPC’s work in 2025.
Thank you for your continued engagement and partnership
Bruce Strober, MD, PhD
President
Christy Langan
Chief Executive Officer
How can clinicians navigate emotionally complex patient interactions while maintaining empathy and trust? In this article, Mio Nakamura discusses communication approaches that may help strengthen patient relationships in dermatology settings.
Read summaries from the IPC symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting covering disease modification, immune pathways, therapeutic escape, and psoriasis treatment response.
In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of systemic corticosteroids in psoriasis. He questions whether they contraindicate the treatment of psoriasis, while also covering his personal experience in prescribing them.
In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of topical corticosteroids in psoriasis, covering current use, guidelines, and consequences.
Missed the joint symposium hosted by the International Eczema Council (IEC) and International Psoriasis Council (IPC) at the American Academy of Dermatology (AAD) Annual Meeting? Select presentations from Psoriasis or Dermatitis? When Boundaries Blur and Treatments Flip the Script are now available, covering diagnostic overlap, emerging tools, treatment-related reactions, and practical strategies for managing complex cases across diverse patient populations.
